Search

everythinglearnresearchcommunity

for

Search:↓

Some dermatological medications can impair male fertility, so consult a doctor before trying to conceive.

Certain medications can cause serious side effects, so it's important to report them.

In 2001, the FDA approved 12 new drugs for children to treat allergies, asthma, ADHD, birth control, and other conditions.

Most dermatologic medications are safe during pregnancy and breastfeeding, but some should be avoided due to potential risks.

Certain drugs that block specific enzymes can help treat prostate diseases.

Researchers developed a method to measure different forms of a drug that could help treat prostate issues and hair loss, and found how these forms behave in animals.

New drugs for alopecia areata show promise but aren't universally effective, and hair loss often returns after stopping treatment.

Anticancer drugs like methotrexate and trimetrexate could be effective and safe for treating malaria at low doses.

Using old drugs for new uses can help treat rare immune deficiencies.

Steroidogenesis inhibitors change but don't stop androgen production in prostate cancer.

5α-reductase inhibitors effectively treat enlarged prostate and hair loss but require careful use due to possible side effects.

New drugs and combination therapies are improving treatment for lower urinary tract symptoms.

Drug repositioning can save time and money but needs more support.

The document concluded that various dermatological treatments have different effectiveness and side effects, with some causing irritation, allergic reactions, or systemic effects.

Antibody drug conjugates show promise in targeting cancer cells while reducing harm to healthy cells.

Using two drugs together, Flutamide and 4-MA, is more effective for blocking male hormones than using each one alone.

5α-reductase inhibitors help treat prostate enlargement and hair loss but may cause side effects, requiring careful use.

Continuous baricitinib is needed to keep hair regrowth in severe alopecia areata.

ALRN-6924 can protect hair follicles from chemotherapy damage by temporarily stopping cell division.

Selective non-steroidal inhibitors of 5α-reductase type 1 can help treat DHT-related disorders.

Using an anti-ICAM-1 antibody with rapamycin improves hair transplant survival in monkeys.

In 2024, the FDA approved 50 new drugs, including treatments for hair loss, anemia, high blood pressure, and Alzheimer's.

5-alpha reductase inhibitors slightly reduce urinary symptoms and may lower surgery and acute retention risks in men.

Certain drugs can cause male infertility, so fertility counseling and sperm preservation are advised.

Many medications can cause hair loss or excessive hair growth, which is usually reversible after stopping the drug.

Certain derivatives are more effective 5α-reductase type 2 inhibitors than finasteride.

Skin reactions to drugs are common and can be deadly, usually requiring stopping the drug and may be better prevented with genetic testing in the future.

Old drugs like finasteride and spironolactone are being successfully used for hair loss and skin conditions, and many other drugs show promise for new uses in dermatology.

Old neuropharmacological drugs might be effective for treating inflammatory skin diseases.

5-alpha-reductase inhibitors help treat urinary symptoms from an enlarged prostate.